CNR2 Antibody (monoclonal) (M01)
Mouse monoclonal antibody raised against a partial recombinant CNR2.
|Application ||WB, IF, E|
|Calculated MW||39681 Da|
|Other Names||Cannabinoid receptor 2, CB-2, CB2, hCB2, CX5, CNR2, CB2A, CB2B|
|Target/Specificity||CNR2 (NP_001832.1, 302 a.a. ~ 360 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.|
|Format||Clear, colorless solution in phosphate buffered saline, pH 7.2 .|
|Storage||Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.|
|Precautions||CNR2 Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The cannabinoid delta-9-tetrahydrocannabinol is the principal psychoactive ingredient of marijuana. The proteins encoded by this gene and the cannabinoid receptor 1 (brain) (CNR1) gene have the characteristics of a guanine nucleotide-binding protein (G-protein)-coupled receptor for cannabinoids. They inhibit adenylate cyclase activity in a dose-dependent, stereoselective, and pertussis toxin-sensitive manner. These proteins have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. The cannabinoid receptors are members of family 1 of the G-protein-coupled receptors.
1.Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity.Brocato B, Zoerner AA, Janjetovic Z, Skobowiat C, Gupta S, Moore Ii BM, Slominski A, Zhang J, Schenone M, Phinehas R, Ferry RJ Jr, Dick E Jr, Hubbard GB, Mari G, Schlabritz-Loutsevitch NPlacenta. 2013 Sep 2. pii: S0143-4004(13)00692-9. doi: 10.1016/j.placenta.2013.08.007.
If you have any additional inquiries please email technical services at email@example.com.